methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate

C46H48N8O8 — CID 67684299

IUPACmethyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
SMILESCOC(=O)N[C@@H]1C(=O)N2[C@H](CC[C@H]2c2ncc(-c3cc4c5c(c3)OCc3cc(-c6cnc([C@@H]7C[C@H](C)CN7C(=O)[C@H](NC(=O)OC)c7ccccc7)[nH]6)cc(c3-5)OC4)[nH]2)CC1C
InChIInChI=1S/C46H48N8O8/c1-23-12-34(53(20-23)43(55)40(52-46(58)60-4)25-8-6-5-7-9-25)42-48-19-32(50-42)27-15-29-22-61-35-16-26(14-28-21-62-36(17-27)38(29)37(28)35)31-18-47-41(49-31)33-11-10-30-13-24(2)39(44(56)54(30)33)51-45(57)59-3/h5-9,14-19,23-24,30,33-34,39-40H,10-13,20-22H2,1-4H3,(H,47,49)(H,48,50)(H,51,57)(H,52,58)/t23-,24?,30+,33-,34-,39-,40+/m0/s1
InChIKeyFKWHIJAEOHUACJ-JGPOGBCSSA-N
MW840.94 g/mol
LogP6.72
Rot. Bonds8

About methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate

methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate (PubChem CID 67684299) has the molecular formula C46H48N8O8 and a molecular weight of 840.94 g/mol. Its IUPAC name is methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate.

Molecular Properties

Compound Namemethyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
PubChem CID67684299
Molecular FormulaC46H48N8O8
Molecular Weight840.94 g/mol
Exact Mass840.36
IUPAC Namemethyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
SMILESCOC(=O)N[C@@H]1C(=O)N2[C@H](CC[C@H]2c2ncc(-c3cc4c5c(c3)OCc3cc(-c6cnc([C@@H]7C[C@H](C)CN7C(=O)[C@H](NC(=O)OC)c7ccccc7)[nH]6)cc(c3-5)OC4)[nH]2)CC1C
InChIInChI=1S/C46H48N8O8/c1-23-12-34(53(20-23)43(55)40(52-46(58)60-4)25-8-6-5-7-9-25)42-48-19-32(50-42)27-15-29-22-61-35-16-26(14-28-21-62-36(17-27)38(29)37(28)35)31-18-47-41(49-31)33-11-10-30-13-24(2)39(44(56)54(30)33)51-45(57)59-3/h5-9,14-19,23-24,30,33-34,39-40H,10-13,20-22H2,1-4H3,(H,47,49)(H,48,50)(H,51,57)(H,52,58)/t23-,24?,30+,33-,34-,39-,40+/m0/s1
InChIKeyFKWHIJAEOHUACJ-JGPOGBCSSA-N
XLogP6.72
TPSA193.10 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds8
Heavy Atoms62
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500840.94
LogP ≤ 56.72
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Analyze methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate?
The IUPAC name of methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate (CID 67684299) is methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate.
What is the SMILES notation for methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate?
The canonical SMILES for methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate is COC(=O)N[C@@H]1C(=O)N2[C@H](CC[C@H]2c2ncc(-c3cc4c5c(c3)OCc3cc(-c6cnc([C@@H]7C[C@H](C)CN7C(=O)[C@H](NC(=O)OC)c7ccccc7)[nH]6)cc(c3-5)OC4)[nH]2)CC1C.
What is the InChIKey of methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate?
The InChIKey is FKWHIJAEOHUACJ-JGPOGBCSSA-N. The full InChI is InChI=1S/C46H48N8O8/c1-23-12-34(53(20-23)43(55)40(52-46(58)60-4)25-8-6-5-7-9-25)42-48-19-32(50-42)27-15-29-22-61-35-16-26(14-28-21-62-36(17-27)38(29)37(28)35)31-18-47-41(49-31)33-11-10-30-13-24(2)39(44(56)54(30)33)51-45(57)59-3/h5-9,14-19,23-24,30,33-34,39-40H,10-13,20-22H2,1-4H3,(H,47,49)(H,48,50)(H,51,57)(H,52,58)/t23-,24?,30+,33-,34-,39-,40+/m0/s1.
What are the key properties of methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate?
methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate has a molecular weight of 840.94 g/mol, XLogP of 6.72, 8 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for methyl N-[(1R)-2-[(2S,4S)-2-[5-[13-[2-[(3S,6S,8aR)-6-(methoxycarbonylamino)-7-methyl-5-oxo-2,3,6,7,8,8a-hexahydro-1H-indolizin-3-yl]-1H-imidazol-5-yl]-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),4(16),5,7,11(15),12-hexaen-6-yl]-1H-imidazol-2-yl]-4-methylpyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate is sourced from PubChem (CID 67684299), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).